Enríquez MJ

Language: Spanish
References: 6
Page: 19-22
PDF size: 309.06 Kb.

ABSTRACT

Perhydrosqualene and collagen-polyvinylpyrrolidone combine in a new high-density, biocompatible, stable filler with very low tissue reactivity and longer durability than other non-permanent materials used in correction of facial volume defects. Due to its higher viscosity, subcutaneous administration results in optimal filling effects. This compound is described as a novel and promising option.

REFERENCES

1. Schuller-Petrovi´c S, Pavlovi´c MD, Schuller SS, Schuller-Luki´c B, Neuhold N. Early “Granulomatous Foreign Body Reactions to a Novel Alginate Dermal Filler: The System’s Failure?”. J Eur Acad Dermatol Venereol 2011; 10: 11-14.

2. Andre P. “New Trends in Face Rejuvenation by Hyaluronic Acid Injections”. J Cosmet Dermatol 2008; 7(4): 251-258.

3. Sánchez-Carpintero I, Candelas D, Ruiz-Rodríguez R. “Dermal Fillers: Types, Indications, and Complications”. Actas Dermo-Sifiliogr 2010; 101(5): 381-393.

4. Furuzawa-Carballeda J, Rojas E, Valverde M, Castillo I, Diaz de León L, Krötzsch E. “Cellular and Humoral Responses to Collagen-Polyvinylpyrrolidone Administered During Short and Long Periods in Humans”. Can J Physiol Pharmacol 2003; 81: 1029-1035.

5. Krötzsch-Gómez FE, Furuzawa-Carballeda J, et al. “Cytokine Expression is Downregulated by Collagen-Polyvinylpyrrolidone in Hypertrophic Scars”. J Invest Dermatol 1998; 111: 828-834.

6. Christian M S. “Final Report on the Safety Assessment of Squalane and Squelene”. J Amer Col Toxicol 1982; 1: 37-54.